<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5210089 Figure_1-A</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Confocal images showing the basal regions of cochlear explants treated with either culture medium alone or medium containing 5 &#181;M, 10 &#181;M, or 20 &#181;M CDDP for 3 days. The explants were labeled with Myosin 7A (red) to identify hair cells and NF200 (green) to highlight auditory nervefibers. Scale bar=20 &#181;m. nf: nerve fibers, OHCs: outer hair cells, IHCs: inner hair cells.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_1-B</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Dose-response curves of CDDP-induced loss of OHCs (blue line) and IHCs (red line) in basal cochlear regions. Data are expressed as mean &#177; SEM (n=5 cochleae per condition and per time point).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_1-C</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Effect over time on OHCs and IHCs treated with either culture medium alone (light blue and red lines for OHCs and IHCs, respectively), or 10 &#181;M CDDP (blue and red lines for OHCs and IHCs, respectively). Data are expressed as mean &#177; SEM (n=5 cochleae per condition and per time point).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_1-D-E</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 1-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D Representative Western blot analysis using antibodies against &#946;-actin and cleaved caspase 3 in whole cochlear extracts. E Histogram representing the change in cleaved caspase 3 expression levels over time in control and CDDP group (n=6 cochleae per condition and per time point). Actin served as a loading control. Data are expressed as mean &#177; SEM. One-way ANOVA test followed by post hoc Tukey's test (*P &#8804; 0.028, **P=0.0007, cochleae at the different times after CDDP exposure vs. control 12h).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_1-F-G</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 1-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F, G Confocal images showing the basal region of cochlear explants treated with either culture medium alone or containing 10 &#181;M CDDP for 1 (F) or 2 (G) days. Hair cells were identified using Myosin 7A (red), phosphatidylserine sites on the cell membrane surface were detected using fluorochrome-labeled Annexin V (green in F), and apoptotic DNA fragmentation was identified using a TUNEL apoptosis kit (green in G). The white arrow heads indicate cell surface Annexin V-positive labeling (lower left) and TUNEL-positive nuclei (lower right). Scale bar=15 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_2-A-J</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 2-A-J</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-J</infon>
    <passage>
      <offset>0</offset>
      <text>A, F Confocal images showing the basal region of organ of Corti cultures treated with either culture medium alone or medium containing 10 &#181;M CDDP for 1 day and immunolabeled for Myosin 7A (red) and &#947;H2AX (green in A), or Myosin 7A (red) and 53BP1 (green in F). The white arrow heads indicate CDDP-induced increase of &#947;H2AX foci in both OHCs and IHCs. Scale bars: A and F=24 &#181;m. B, G Higher magnification images of representative OHC and IHCnuclei from all conditions tested. Scale bar=5 &#181;m. C, H Histograms displaying green fluorescent signal intensity of x-projections and 3D reconstruction images from OHC and IHCnuclei presented in B and G, respectively. F0 corresponds to background noise, gray dashed lines represent the threshold used to detect specific foci labeling. 3D images were reconstructed according to the threshold defined in the histograms of all conditions tested. Scale bar=5 &#181;m. D, E, I Quantification analysis of &#947;H2AX foci number (D); total volume of foci per nucleus (E); 53BP1 foci number (I) from OHCs and IHCs treated with either culture medium alone (light blue and red lines for OHCs and IHCs, respectively), or 10 &#181;M CDDP (blue and red lines for OHCs and IHCs, respectively, n=50 nuclei per condition and per time point). Data are expressed as mean &#177; SEM. One-way ANOVA test followed by post hoc Tukey's test (D: **P=0.007; E and I: **P &#8804; 0.009. CDDP-exposed OHCsvs. CDDP-exposed IHCs). J Higher magnification images showing representative OHCnuclei from the basal region of the organ of Corti treated with 10 &#181;M CDDP for 1 day and immunolabeled for 53BP1 (red), &#947;H2AX (green) and counterstained with Hoechst (blue). The 3D image shows co-localization of smaller sized 53BP1 foci within the &#947;H2AX foci. Scale bar=5 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_3-A-E</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 3-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>A Confocal images showing the basal region of organ of Corti cultures treated with either culture medium alone or medium containing 10 &#181;M CDDP for 1 day and immunolabeled for Myosin 7A (red) and p-ATM (green). Scale bar=15 &#181;m. B Higher magnification images showing representative OHC and IHCnuclei from control and CDDP-exposed cells. Scale bar=5 &#181;m. C Histograms displaying green fluorescent signal intensity of x-projections of OHC and IHCnuclei from control and CDDP-exposed cells. D Quantification analysis of p-ATM foci numbers in both OHCs and IHCs exposed to either culture medium alone (light blue and red lines for OHCs and IHCs, respectively) or 10 &#181;M CDDP (blue and red lines for OHCs and IHCs, respectively, n=50 nuclei per condition and per time point). Data are expressed as mean &#177; SEM. One-way ANOVA test followed by post hoc Tukey's test (**P&lt;0.008, ***P=0.00005, CDDP-exposed OHCsvs. CDDP-exposed IHCs). E Higher magnification confocal and 3D images showing the co-localization of p-ATM foci (green) with 53BP1 foci (red) in an OHCnucleus from the basal region of the organ of Corti culture treated with 10 &#181;M CDDP for 1 day. Scale bar=5 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_3-F-G-H</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 3-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>F Confocal images showing the basal region of organ of Corti cultures treated with either culture medium alone or medium containing 10 &#181;M CDDP for 1 day and immunolabeled for Myosin 7A (red) and p-Chk2 (green). Scale bar=15 &#181;m. G Histograms of green fluorescent signal intensity from OHC and IHCnuclei of a CDDP-treated organ of Corti explant. H Quantification of Chk2-positive nuclei in both IHCs (red bars) and OHCs (blue bars) from control and CDDP-treated organ of Corti cultures (n=50 nuclei per condition and per time point). Data are expressed as mean &#177; SEM. Kruskal-Wallis test followed by post hoc Dunn's test (*P=0.045, ***P=0.0002, CDDP-exposed IHCsvs. control IHCs; CDDP-exposed OHCsvs. control OHCs).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_3-I-J-K</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 3-I-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_3-I-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>I Representative western blots using antibodies against p-p53 (serine 15), p53 and &#946;-actin in control and 10 &#181;M CDDP-exposed whole cochlear extracts. J-K Histograms representing the levels of total p53 protein (J) and p53 phosphorylation (K) in control (gray bars) and CDDP-exposed cochleae (green bars, n=6 cochleae per condition and per time point). Actin served as a loading control. Data are expressed as mean &#177; SEM. One-way ANOVA test followed by post hoc Tukey's test (J: *P &#8804; 0.023; K: *P=0.032, **P=0.007, ***P &#8804; 0.0008, cochleae at the different times after CDDP exposure vs. control 12h).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_4-A-B</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A 3D images of OHCnuclei taken from the basal regions of organ of Corti cultures treated with medium alone, 10 &#181;M KU55933, 10 &#181;M CDDP or 10 &#181;M CDDP in combination with 10 &#181;M KU55933 for 1 day and immunolabeled for 53BP1 (green) and Hoechst 33342 (blue). Scale bar=5 &#181;m. B Quantification analysis of 53BP1 foci number per nucleus in both IHCs (red bars) and OHCs (blue bars) for all conditions (n=50 nuclei per condition and per time point). Data are expressed as mean &#177; SEM. One-way ANOVA test followed by post hoc Tukey's test (***P &#8804; 0.0004, CDDPvs. control, or CDDPvs. CDDP+KU55933).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_4-C-D</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Confocal images showing the basal region of the organ of Corti cultures treated with medium alone, 10 &#181;M KU55933, 10 &#181;M CDDP or 10 &#181;M CDDP in combination with 10 &#181;M KU55933 for 5 days and immunolabeled for Myosin 7A (red). Scale bar=24 &#181;m. D Histograms representing the numbers of surviving IHCs (red bars) and OHCs (blue bars) for all treatment conditions after 5 days (n=5 cochleae per condition and per time point). Data are expressed as mean &#177; SEM. One-way ANOVA test followed by post hoc Tukey's test (*P=0.03, **P =0.004, ***P &#8804; 0.0008, CDDPvs. control, or CDDPvs. CDDP+KU55933).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_4-E-F</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E 3D images of OHCnuclei from the basal regions of organ of Corti cultures treated with culture medium alone, 100 &#181;M PFT-&#945;, 10 &#181;M CDDP or 10 &#181;M CDDP in combination with 100 &#181;M PFT-&#945; for 1 day and immunolabeled for 53BP1 (green) and Hoechst 33342 (blue). Scale bar=5 &#181;m. F Quantification of 53BP1 foci number per nucleus in both IHCs (red bars) and OHCs (blue bars) for all conditions (n=50 nuclei per condition and per time point). Data are expressed as mean &#177; SEM. One-way ANOVA test followed by post hoc Tukey's test (***P &#8804; 0.0007, CDDPvs. control).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_5-A-B-C</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 5-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A Representative auditory brainstem response (ABR) waveforms evoked by 16 kHz tone-bursts in p53wt mice treated with saline (black plot) or CDDP (green plot), and p53-/- mice treated with saline (light blue plot) or CDDP (dark blue plot) for 5 days. B ABR thresholds recorded in p53wt mice before (gray plot) and after 5 days of saline (black plot) or CDDP treatments (green plot), and ABR thresholds recorded in p53-/- mice before (light gray plot), and after 5 days of saline (light blue plot) or CDDP treatment (dark blue plot). C Mean ABR threshold from 4 kHz to 32 kHz derived from B. Data are expressed as mean &#177; SEM (saline treated-group: n=7, CDDP treated-group: n=12). One-way ANOVA test followed by post hoc Tukey's test (**P &#8804; 0.008, p53wt+CDDP, d5 vs. p53wt, before or p53wt+CDDP, d5 vs. p53-/- + CDDP, d5).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_5-D</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Representative scanning electron microscopy micrographs showing the basal regions of cochleae from CDDP-treated p53wt and p53-/- mice after 5 days. Scale bar=15&#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_5-E</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Cytocochleograms representing the percentage of surviving hair cells in four cochlear regions located at 1.1, 2.6, 3.5 or 4.1 mm from the cochlear apex provided from saline-treated p53wt mice (black bars), CDDP-treated p53wt mice (green bars) or p53-/- mice (blue bars), after 5 days (n=5 per group). Data are expressed as mean &#177; SEM. Kruskal-Wallis test followed by post hoc Dunn's test (**P &#8804; 0.008, p53wt+CDDP, d5 vs. p53wt+saline, d5 or p53wt+CDDP, d5 vs. p53-/- + CDDP, d5).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_5-F-G</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 5-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F ABR thresholds from p53wt mice recorded prior to (gray plot) or after 5 days systemic treatment with: DMSO (yellow plot), CDDP+DMSO (green plot), CDDP+PFT-&#945; (pink plot). G Mean ABR threshold from 4 kHz to 32 kHz derived from F. Data are expressed as mean &#177; SEM (DMSO treated-group: n=7; CDDP+DMSO treated-group: n=12; CDDP+ PFT-&#945;-treated group: n=12). One-way ANOVA test followed by post hoc Tukey's test (***P &#8804; 0.0005, CDDP+DMSO, d5 vs. before or CDDP+DMSO, d5 vs. CDDP+PFT-&#945;, d5).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_5-H</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Cytocochleograms representing the percentage of surviving hair cells in four cochlear regions located at 1.1, 2.6, 3.5 or 4.1 mm from the cochlear apical end taken from p53wt mice treated with: DMSO (yellow bars), CDDP+DMSO (green bars), CDDP+PFT-&#945; (pink bars), after 5 days (n=5 per group). Data are expressed as mean &#177; SEM. Kruskal-Wallis test followed by post hoc Dunn's test (**P &#8804; 0.008, CDDP+DMSO, d5 vs. DMSO, d5 or CDDP+DMSO, d5 vs. CDDP+PFT-&#945;, d5).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_5-I-J</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 5-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>I ABR thresholds from p53wt mice recorded prior to (gray plot and black plot for left and right ear, respectively) or after 5 days of systemic treatment with CDDP plus intratympanic injection of DMSO into the left ear (green plot), and of PFT-&#945; into the right ear (pink plot). J Mean ABR threshold from 4 kHz to 32 kHz derived from I. Data are expressed as mean &#177; SEM (n=14). One-way ANOVA test followed by post hoc Tukey's test (***P = 0.0003 , CDDP+left ear, DMSOvs. before, left ear or CDDP + left ear, DMSOvs. CDDP + right ear, PFT-&#945;.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_5-K</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 5-K</infon>
    <infon key="sourcedata_figure_dir">Figure_5-K</infon>
    <passage>
      <offset>0</offset>
      <text>K Cytocochleograms representing the percentage of surviving hair cells in four cochlear regions located at 1.1, 2.6, 3.5 or 4.1 mm from the cochlear apical end taken from the DMSO-treated left ear (green bars) and PFT-&#945; treated right ear (pink bars) of the same CDDP-treated p53wt mice after 5 days (n=5 per group). Data are expressed as mean &#177; SEM. Kruskal-Wallis test followed by post hoc Dunn's test (**P &#8804; 0.008, CDDP + right ear, PFT-&#945; vs. CDDP+left ear, DMSO).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_6-A-B-E-F</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 6-A-B-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>A ABR thresholds recorded prior to (gray plot) or at day 28 in HBCx-90 (TP53 wt) bearing-mice received systemic treatment with: DMSO (black plot), PFT-&#945; (yellow plot), CDDP (green plot), CDDP+PFT-&#945; (pink plot). B Mean ABR threshold from 4 kHz to 32 kHz derived from A. Data are expressed as mean &#177; SEM (before: n=20; DMSO: n=5; PFT-&#945;: n=5; CDDP: n=5; CDDP+PFT-&#945;: n=5). One-way ANOVA test followed by post hoc Tukey's test (***P = 0.0002, CDDP vs. before; CDDP vs. CDDP+PFT-&#945;. E ABR thresholds recorded prior to (gray plot) or at day 35 in HBCx-14 (TP53 mutant) bearing-mice received systemic treatment with: DMSO (black plot), PFT-&#945; (yellow plot), CDDP (green plot), CDDP+PFT-&#945; (pink plot). F Mean ABR threshold from 4 kHz to 32 kHz derived from E. Data are expressed as mean &#177; SEM (before: n=30; DMSO: n=5; PFT-&#945;: n=5; CDDP: n=10; CDDP+PFT-&#945;: n=10). One-way ANOVA test followed by post hoc Tukey's test (***P = 0.0003, CDDPvs. before or CDDPvs. CDDP+PFT-&#945;.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_6-C-G</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 6-C-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-G</infon>
    <passage>
      <offset>0</offset>
      <text>C Cytocochleograms representing the percentage of surviving hair cells in three cochlear regions located at 1.1, 2.6, and 3.5 mm from the cochlear apical end. These cochleae (n=5 per group) were collected at 28 days from the beginning of treatment with DMSO (black bars), PFT-&#945; (yellow bars), CDDP (green bars), or CDDP+PFT-&#945; (pink bars). Data are expressed as mean &#177; SEM. Kruskal-Wallis test followed by post hoc Dunn's test (**P &#8804; 0.007, CDDP, d28 vs. DMSO, d28 or CDDP, d28 vs. CDDP+PFT-&#945;, d28). G Cytocochleograms representing the percentage of surviving hair cells in three cochlear regions located at 1.1, 2.6, and 3.5 mm from the cochlear apical end. These cochleae (n=5 per group) were collected at 35 days from the beginning of treatment with DMSO (black bars), PFT-&#945; (yellow bars), CDDP (green bars), or CDDP+PFT-&#945; (pink bars). Data are expressed as mean &#177; SEM. Kruskal-Wallis test followed by post hoc Dunn's test (**P &#8804; 0.008, CDDP, d35 vs. DMSO, d35 or CDDP, d35 vs. CDDP+PFT-&#945;, d35).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_6-D-H</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 6-D-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D-H</infon>
    <passage>
      <offset>0</offset>
      <text>D Tumor growth curves alongside images of dissected tumors collected on day 28. Note the partial inhibition of growth in CDDP and CDDP+PFT- &#945;-treated mice. H Tumor growth curves alongside images of dissected tumors collected on day 35. Note the complete disappearance of tumors at day 35 and the significantly reduced tumor regrowth up to day 70 in CDDP+PFT- &#945;-treated mice.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_7-A-B</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 7-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Representative confocal images of microvessels in transversal tumor sections from HBCx-14 (TP53mutant) tumors treated with either DMSO, CDDP or a combination of CDDP and PFT-&#945;. The sections were immunolabeled for CD31 (red) and viewed with a 20x objective. The basal-like breast cancer cells were immunolabeled in green with an antibody against cytokeratin 5 and 8. Upper right panel is a 2D projection from the white boxed area in upper left panel. The red area corresponds to CD31 labeled endothelial area and the white area represents the lumen area. The white line shows the vessel perimeter. Scale bars: left panel=50 &#181;m, right panels=35 &#181;m. The tumor samples were collected at day 21. B Histograms representing the percentage of vascular area calculated using 2D reconstruction image analysis and the formula: vessel/vascular area = area of CD31-positive objects + lumen area per field area &#215; 100 %. The both HBCx-14 (TP53mutant) and HBCx-90 (TP53wt) tumors from the different treated groups were collected at day 21 (n=4 sections/tumor and 3-4 tumors/group). Data are expressed as mean &#177; SEM. Kruskal-Wallis test followed by post hoc Dunn's test (***P &#8804;0.0004, CDDPvs. DMSO or CDDPvs. CDDP+PFT-&#945;).</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_7-C</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Representative confocal images of cleaved caspase 3 positive cells (red) in the transversal tumor sections and viewed with a 20x objective. The stromal compartments were immunolabeled in green with an antibody against vimentin. HBCx-14 (TP53mutant) tumors from the different treated groups were collected at day 18. Scale bar=50 &#181;m. c-cas-3: cleaved caspase 3.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_7-D</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Representative western blot analysis using antibodies against &#946;-actin, p53 and p21 in tumor extracts from HBCx-14 (TP53mutant) and HBCx-90 (TP53 wt) tumors treated with either DMSO or CDDP and collected at day 18. Note the higher CDDP-induced increase of p53 and p21 expression in TP53wt HBCx-90tumors.</text>
    </passage>
  </document>
  <document>
    <id>5210089 Figure_7-E-I</id>
    <infon key="sourcedata_document">2428</infon>
    <infon key="doi">10.15252/emmm.201606230</infon>
    <infon key="pmc_id">5210089</infon>
    <infon key="figure">Figure 7-E-I</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E-I</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Representative western blot analysis using antibodies against &#946;-actin, p-Chk1, Beclin 1, LC3-I/II and Rab7 in tumor extracts from HBCx-14 (TP53mutant) and HBCx-90 (TP53 wt) tumors treated with either DMSO, PFT-&#945;, CDDP or a combination of CDDP and PFT-&#945;. The tumor samples were collected at day 18. G, H, I Histograms representing the levels of Beclin 1, LC3-II and Rab7 in HBCx-14 and HBCx-90tumors treated with the different regimens (n=3-4 tumors per group, all experiments were performed in triplicate). Actin served as a loading control. Data are expressed as mean &#177; SEM. One-way ANOVA test followed by post hoc Tukey's test (G: *P = 0.03, **P =0.006 , ***P &#8804; 0.0004 ; H: *P =0.02, ***P = 0.0005 ; I: *P =0.03, ***P &#8804; 0.0006 , CDDPvs. DMSO or CDDPvs. CDDP+PFT-&#945;).</text>
    </passage>
  </document>
</collection>
